The landscape of dementia analysis has advanced considerably with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology years right before indicators emerge. Though these technological improvements represent amazing progress in being familiar with neurodegenerative conditions, they have not https://mild-cognitive-impairment77665.madmouseblog.com/18712919/the-enduring-price-of-cognitive-evaluation-for-older-older-people